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ABSTRACT  
SeDeM design expert technique used to evaluate the risks of poor flow of pharmaceutical powders under preformulation studies which reveals 
direct compression suitability and prepare robust composition of active pharmaceutical ingredient (API) and excipient in tablets formulation. 
The purpose of this study was to develop oral disintegrating tablets of Furosemide using different concentration of natural a nd synthetic 
superdisintegrants by means of SeDeM design technique. Oral disintegrating tablets (ODT) of Furosemide were prepared by direct compression 
technique using isolated banana powder and croscarmellose sodium (Ac-di-sol) together with microcrystalline cellulose as superdisintegrants. 
SeDeM design was performed to check suitability and deficient of excipients and drug for optimized composition derived based on IPP value. 
These tablets were evaluated for hardness, friability, drug content, weight variation, wetting time and in-vitro dissolution. All the formulations 
showed low weight variation with dispersion time less than 173.5±0.70 seconds and rapid in-vitro dissolution. The drug content of all the 
formulations was within the acceptable limits. Lubricated blend composition of F4 found average radius value 5.24, 0.66 and 5.509 for IGC, IP 
and IPP respectively, compressed tablet shown good physical properties. The optimized formulation F4 showed good release profile with 99.25 
percentage drug release compared to other trial batches. It was concluded that natural superdisintegrant (banana powder) showed better 
disintegrating property than synthetic super disintegrant (Ac-di-sol) in the formulations of ODTs. 
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INTRODUCTION 
Oral disintegrating tablets is rapidly gaining acceptance as an 
important new drug delivery technology. ODTs are intended 
to disperse, dissolve, or disintegrate quickly in the mouth 
cavity due to saliva, which results in release of the drug due 
to rapid absorption of the medium into the tablet core 
followed by prompt tablet disintegration under the effect of 
superdisintegrants [1]. Orally disintegrating tablets provide 
an advantage particularly for pediatric and geriatric 
populations who have difficulty in swallowing conventional 
tablets and capsules. Moreover, patients travelling with little 
or no access to water, limit utility of orally administered 
conventional tablets or capsules [2]. Drug candidates that 
undergo pre-gastric absorption when formulated as ODTs 
may show increased oral bioavailability. The natural origin 
polymer is preferred over semi-synthetic and synthetic 
substances because they are comparatively cheaper, 
abundantly available, non-irritating and non-toxic in nature 
[3-4].  
A direct compression method has many advantages such as 
low cost, just enough conventional equipment, less 
processing steps. In addition high doses of drug, heat and 
moisture sensitive drugs could be prepared by this method 
[5]. But due to poor flow property and deficient properties of 
drug during drug product manufacturing campaigns were 
faced lot of problems. In direct compression case its 
recommended to employ excipient which has good flow or 
which are directly compressible grade qualitatively, to 
incorporate such excipient quantitatively is always a task for 
the formulator. While developing the formulation, cautious 
and specific to select concentration of excipient is important 
to be achieving by accessing inactive ingredient database of 
USFDA which provide the safe level of particular excipient as 
per dosage form and route of administration as well. In the 
current SeDeM expert system shows the suitability of API 
and excipient for direct compression process and % 
concentration of excipient or polymer to be incorporated in 
the formulation to mask poor flow characteristic of API. This 
optimization tool is well reported in literature as well as in 
scientific books [6]. For the present study different excipient 
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is used to correct the API’s poor flow and make it suitable for 
direct compression using (SeDeM) Secure Development 
Method expert system. This system provides prediction of 
flow and a physical profile of drug and excipients intended to 
be used [7]. SeDeM expert system may be coined as time 
saving as this technique may reduce no of trials. Due to the 
ability of prediction for deficient part this technique may 
serve as economic and choice of technique compared to 
other time consuming conventional trial and error approach 
or software based prediction models.  
Furosemide (FUR), 5-(aminosulphonyl)-4-chloro-2-[(2-
fuanyl-methyl) amino] benzoic acid, is a potent loop (high 
ceiling) diuretic used in the treatment of edematous states 
associated with congestive heart failure, cirrhosis of the liver, 
renal disease and chronic hypertension. According to the 
biopharmaceutical classification system (BCS), FUR is 
classified as a class IV drug due to its low solubility (5–20 
mg/mL) and low permeability. Therefore, low oral 
bioavailability of FUR has been reported. Because of its weak 
acidic properties (pKa 3.8), furosemide is mostly absorbed in 
the stomach and upper intestine, but also from the oral 
mucosa following sublingual administration [8]. Therefore, 
the purpose of this study was to optimize suitable blends 
using SeDeM expert system, formulate and evaluate a 
furosemide ODT by means of a direct compression method. 
The effects of the superdisintegrants i.e. croscarmellose 
sodium and banana powder on the tablets disintegration, 
dissolution and swelling properties of ODT were compared. 
MATERIALS AND METHODS  
Materials 
Furosemide was gifted by Glen mark pharmaceuticals Pvt. 
Ltd. Nashik, India, croscarmellose sodium, aspartame and 
magnesium stearate were gifted by Gebbs pharmaceuticals 
Pvt. Ltd, Nashik, India. Banana powder was obtained from 
Saipro food, Pune, India. All other materials and chemicals 
used were of either pharmaceutical or analytical grade. 
Methods 
Drug-excipients compatibility  
Compatibility studies of pure drug and excipients were 
carried out using Fourier transformed infrared 
spectrophotometer (Shimadzu, Japan) in the range of 400-
4000 cm-1 by KBr disc method. A base-line correction was 
made using dried potassium bromide and then the spectrum 
of the pure furosemide and physical mixture 
(drug/excipients) were obtained. 
Parameters of SeDeM expert system for material 
properties [9] 
Powder material including excipient and drug was evaluated 
for different parameters according to the SeDeM expert 
system to determine their suitability for direct compression. 
Some of them were determined experimentally according to 
the established procedure and some were calculated from 
experimental values as per Table 1. 
1) Bulk density (Da) and Tapped density (Dc) 
Graduated cylinder was employed for density 
measurements and the volume taken was the value 
obtained before and after 250 strokes using a settling 
apparatus.  
2) Inter-particle porosity (Ie), Carr index (IC %) and 
Hausner’s ratio (IH) 
The inter-particle porosity, Carr index and Hausner’s ratio 
of the drug powder was calculated by the following equation 
given in Table 1. 
3) Cohesion index (Icd) 
The cohesion index was determined by directly 
compressing the drug powder using an eccentric press. The 
hardness (N) of the obtained tablets was determined. 
4) Angle of repose (α) 
Angle of repose is the maximum angle possible between the 
surfaces of apex of the powder to the horizontal plane. The 
accurately weighed powder and blend it then it was put in 
the funnel. The height of the funnel was adjusted as per 
specification in such a way the tip of the funnel just touched 
to the apex of the powder blend. The powder blend was 
allowed to flow through the funnel freely on to the surface. 
The radius of the cone base was measured with a slide 
caliper and the mean value (r) was calculated. Additionally, 
the cone height (h) was measured and the angle tangent 
value (α) of the cone was calculated employing the 
following equation: tan α = h/r. 
5) Flowability (tn) 
The flow rate described herein as flowability was 
determined in accordance with the method described in 
Section 2.9.16-2 of European Pharmacopoeia as the time for 
a fixed amount of powder to flow through a glass tunnel with 
0.85 cm orifice diameter. It was expressed in seconds and 
tenths of a second per 100 gm of sample, with the mean 
value of three determinations always being taken.
 
Table 1: Parameters of SeDeM expert system along with limits and factors 
Incidence factor Parameter Unit Equation (v) Limits Radius (r) 
Dimension 
Bulk density (Da) g/mL Da=P/Va 0–1 10v 
Tapped density (Dc) g/mL Da=P/Vc 0–1 10v 
Compressibility 
Inter-particle porosity (Ie) - Ie=Dc-Da/Dc×Da 0–1.2 10v/1.2 
Carr index (Ic) - Ic= (Dc-Da/Dc)×100 0–50 v/5 
Cohesion index (ICD) N Experimental 0–200 v/20 
Flowability/ 
powder flow 
Housners ratio (IH) - IH=Dc/Da 3–1 (30-10v)/2 
Angle of repose (α) ᵒ tan θ=h/r 0–50 10-(v/5) 
Powder flow (tn) S Experimental 0–20 10-(v/2) 
Lubricity/ 
stability 
Loss of drying (% HR) % Experimental 0–10 10-v 
Hygroscopicity (%H) % Experimental 0–20 10-(v/2) 
Lubricity/ 
dosage 
Particle <5μm (%Pf) % Experimental 0–50 10-(v/5) 
Homogeneity index (Iθ) - Iθ=Fm/100+Fmn 0-2×102 500v 
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6) Loss on drying (% HR)  
Excipient was dried in a convection oven at 105°C ± 
2°C until a constant weight is obtained. 
7) Hygroscopicity (% H) 
The hygroscopicity of a powder is its equilibrium 
moisture content after being exposed to air humidity 
under given conditions. It was determined by 
calculating the increase in sample weight after being 
kept in a humidifier at ambient relative humidity of 
76% ± 2% and a temperature of 22°C ± 2°C for 24 h. 
8) Percentage of particles measuring < 50 μ (% Pf)  
Particle size was determined by means of the sieve test 
in accordance with the General method 2.9.12 of 
European Pharmacopoeia and was expressed as the % 
of particles that pass through a 0.05 mm sieve, when 
vibrated for 10 min at speed 10 using a sieve vibrator. 
9) Homogeneity index (Iθ)  
The method for determination of Iθ was based on General 
method 2.9.12 of European Pharmacopoeia for determining 
particle size by means of the sieve test. The grain size of a 
100 g sample was determined by submitting a sieve stack to 
vibration for 10 min at the speed 10 using a sieve vibrator. 
Sieve sizes used were: 0.355, 0.212, 0.100 and 0.05 mm. The 
percentage of product retained in each sieve and the 
quantity that passes through the 0.05 mm sieve were 
calculated. The percentage of fine particles (<50μ) 
determined previously in a separate operation was 
considered. The following equation 1 was then applied to the 
data obtained: 
                                    
                                 
                        .............. (1) 
Where, Iθ= Relative homogeneity index, Fm= % of particles 
in the majority range, Fm−1=% of particles in the range 
immediately below the majority range, Fm+1= % of particles 
in the range immediately above the majority range, n= order 
number of the fraction studied under a series, with respect 
to the major fraction, dm= mean diameter of the particles in 
the major fraction,dm−1= mean diameter of the particles in 
the fraction of the range immediately below the majority 
range, dm+1= mean diameter of the particles in the fraction 
of the range immediately above the majority range.
 
Table 2: Distribution of particles in the determination of Iθ 
Sieve mm 
Corresponding 
fraction 
Average of the 
diameter of the 
fraction 
Corresponding 
diameter 
(dm ... dm ± n) 
Dif dm with 
the mayor 
component 
0.355-0.500 Fm+2 100 dm+2 25 
0.212-0.355 Fm+1 90 dm+1 15 
0.100-0.212 Fm 75 dm 0 
0.050-0.100 Fm-1 66 dm-1 9 
˂ 0.050 Fm-2 52 dm-2 23 
 
Conversion of experimental values to radius value for 
graphical presentation of SeDeM diagram 
The numerical values for different parameters of the 
material obtained by experimental determination were 
converted into a radius value ‘r’ of the SeDeM expert system 
diagram. For the conversion of experimental value of each 
parameter, specific factors were applied4 as listed in Table 
1. SeDeM diagram was drawn on the basis of 12 parameters 
[10]. Results obtained from the experimental determination 
of various parameters were converted and presented as a 
SeDeM diagram (figure 1). 
Calculation of acceptance values of indices 
For determination of suitability of the material for direct 
compression the following indices are calculated on the 
basis of the SeDeM system [11]. 
Parameter index  
I.P. = No. P ⩾/ 5 No. Pt......... (2) 
Where, No. P ⩾ 5 = Parameters with values equal to or more 
than 5; No. Pt = Total number of parameters.  
Parameter profile index 
I.P.P. = Average of radius all parameters  
Average (r) = mean radius value of all parameters/ 
no. of parameters...... (3) 
Good compressibility index  
I.G.C. = I.P.P. × f.................... (4) 
Where, f = Reliability factor = Polygon area / Circle area 
The acceptability limit is greater than and equals to 5 in all 
cases. For 12 parameters f value = 0.952, for 8 parameters f 
value =0.900 
 
Figure 1: SeDeM diagram for 12 parameters 
Application of SeDeM expert system to overcome 
deficient API properties [9] 
For correction the deficiency of poor flow API required 
amount of excipient was determined using equation 4. This 
equation allows calculation of the amount of excipient 
required to compress the API on the basis of the SeDeM 
radius considering 5 (min) for each parameter of incidence 
which allows correct compression;  
CP = 100 − [(RE − R)/(RE − RP) × 100].................. (4) 
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Where CP = % Corrective Excipient; RE = mean-incidence 
radius value (compressibility) of the corrective excipient; R 
= mean-incidence radius value to be obtained in the blend; 
RP = mean-incidence radius value (compressibility) of the 
API to be corrected. 
Blending and tableting for oral disintegrating tablet 
Oral disintegrating tablet of furosemide were prepared by 
using direct compression method based on the radius values 
obtained on API and excipient as well as % corrective 
excipient requirement formulation F1 to F6 derived 
according to the formulae as shown in Table 3. This method 
involves a simple procedure of blending of API with other 
ingredients and the resulted mixture is subjected to direct 
compaction. The required ingredients were taken in a 
mortar and the powder blend was mixed for a time period of 
15-20 min by using mortar and pestle. Then each mixture 
was passed through sieve no.60 and finally magnesium 
stearate was added as lubricant and thoroughly mixed. The 
blend were subjected to 12 test of SeDeM as per Table 1, 
result obtained were calculated for radius values, on the 
basis of radius values SeDeM diagram was plotted, 
acceptance values were calculated using parameter index, 
parameter profile index and good compressibility index 
equations of composition whose blend yielding higher IPP 
value (mean r of all parameters) was considered as 
optimized batch for further evaluation. The ooptimized 
powder blend was compressed in to tablets on twelve 
station rotary punch-tableting machine (Karnavati, Rimek 
Mini Press- 2) using 8 mm concave punches. 
Table 3: Formulation of Furosemide ODT by direct 
compression method 
Ingredients (mg) F1 F2 F3 F4 F5 F6 
Furosemide 20 20 20 20 20 20 
Microcrystalline 
cellulose 
10
0 
12
0 
11
5 
12
1 
11
7 
11
0 
Cross carmellose 
sodium 
8 10 15 - - - 
Banana powder - - - 9 13 20 
Mannitol 44 44 44 44 44 44 
Magnesium Stearate 4 4 4 4 4 4 
Aspartame 2 2 2 2 2 2 
 
Evaluation of Furosemide ODT 
Quality control tests such as thickness, diameter and 
hardness, weight variation, friability, wetting time and water 
absorption ratio, disintegration and dissolution were 
performed on the ODTs. 
Thickness, diameter and hardness determination  
The thickness and diameter of 10 tablets from each 
formulation was measured using a Vernier caliper. The 
hardness of tablet of each formulation was measured by 
Monsanto hardness tester. Thickness, diameter and 
hardness tests were performed on ODTs using Pharma Test 
PTB, Germany. Thickness, diameters (mm), and hardness 
(kg/cm2) values were expressed as an average of 10 
measurements.  
Weight variation  
20 tablets were chosen randomly and then weighed 
individually using an analytical balance. The mean weight 
was calculated, and individual tablet weight was compared 
to the mean weight to assure whether it was within 
permissible limits or not. 
Friability test 
This test is performed to evaluate the ability of tablets to 
withstand abrasion in packing, handling and transporting. 
Initial weight of 20 tablets is taken and these are placed in 
the Roche friabilator, rotating at 100 rpm for 4 min. The 
tablets are then taken out, dedusted and were weighed. The 
difference in the weight is noted and expressed as 
percentage. 
Content uniformity  
Twenty tablets were crushed and powder equivalent to 
weight of one tablet was dissolved in phosphate buffer 6.8. 
Then suitable dilutions were made and absorbance at 276 
nm wavelength was taken by using a UV visible 
spectrophotometer.  
Wetting time and water absorption ratio 
For measurement of wetting time and water absorption 
ratio of ODTs, a piece of tissue paper folded twice was placed 
in a petri dish with a 10 cm diameter containing 6 mL of 
purified water. A previously weighed tablet was placed on 
the surface of the tissue paper, and the time to wet the tablet 
completely was noted as the wetting time [12]. The fully 
wetted tablet was weighed and the water absorption ratio, R, 
was calculated as follows,  
R = 100 (Wa-Wb)/Wb................ (5) 
Where, Wb is weight of tablet before water absorption Wa is 
weight of tablet after water absorption. 
Disintegration time 
Disintegration test was performed according to the Ph. Eur. 
8th with six tablets, and distilled water as the medium. The 
time required for complete disintegration of each tablet was 
recorded individually.  
In-vitro dissolution tests for ODT 
Dissolution test was performed on six ODTs in 900 mL of pH 
5.8 phosphate buffer at 37±0.5°C using Apparatus 2 (paddle 
method, 50 rpm). At predetermined time intervals (5, 10, 15, 
20, 30, 45, 60 min); samples (2 mL) were withdrawn and 
replaced with fresh dissolution medium. The samples were 
filtered through 0.45 μm membrane filter and analyzed on 
UV spectrophotometer (Shimadzu 1800) at 276 nm to 
determine drug content. 
Stability study 
Stability studies at 40°C ±2°C /75% ± 5% RH was carried out 
for 3 months for optimized tablets (F4). The oral 
disintegrating tablets were observed for colour, friability, 
hardness, disintegration time, in-vitro drug release and assay 
3 months respectively [13]. 
RESULTS AND DISCUSSION 
FTIR studies were conducted and the spectrum was 
recorded in the range of 4000-400cm-1. The study of IR 
spectra of Furosemide shows Carboxylic acid (COOH), S=O 
stretching vibrations of sulphonamide group, N-H stretching 
vibration of secondary amine, C=O stretching, and C-Cl 
stretching vibrations appeared at 1440-1395, 1370-1335, 
3350-3250, 1310-1250 and 550-850 cm-1 respectively [14]. 
The major peaks of physical mixture of formulation F4 after 
compression was found to be 1570.12, 1319.37, 3398.72, 
1249.93, 668.97 cm-1 for Carboxylic acid (COOH), S=O 
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stretching vibrations of sulphonamide group, N-H stretching 
vibration of secondary amine, C=O stretching, and C-Cl 
stretching vibrations respectively. It was observed that there 
were no changed in these main peak in IR spectra of mixture 
of drug and polymer after compression of tablet, which show 
there were no physical interaction. The peak obtained in the 
spectra of each formulation correlate with the peak of drug 
spectrum.  
The choice of excipients is very important for the 
development of a tablet formulation and also for the quality 
control of dosage forms. A very limited number of excipients 
are used for direct compression due to flowability, 
compressibility, and stability properties. MCC is widely used 
as filler in tablets but cause an increase in the dissolution 
rates and hardness of tablets compared to other fillers. ODTs 
disintegrate in the mouth in a short period of time, so that 
taste masking is very important especially for bitter tasting 
active ingredients. Various parameters of a powder blend 
according to SeDeM system estimated for suitability of direct 
compression. 12 parameters values determined for the ODT 
powders are listed in figure 2. Furosemide is white a poor 
flow powder by 12 parameters as per SeDeM system. The 
flow property of the Furosemide was improved by addition 
of excipients which have 5 and above radius values. The 
radius values of API shows that the bulk density (3.846), 
tapped density (4.166), inter particle porosity (1.66), 
cohesive index (4.35), angle of repose (2.65), flow property 
(2), and homogeneity index (4.35).  Firstly, improved the 
dimension (bulk density, tapped density) of the Furosemide 
that shows mean radius under the value 5 which improved 
by addition of the mannitol in it because it’s mean radius 
value is above 5 (6.427) which is largest in all excipients. 
Void fraction of tapped and loosely packed powder particles 
have been used for determination of size, void space and 
shape of particles (Figure 2).  
 
Figure 1: SeDeM diagram of excipients and furosemide 
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Then improved the compressibility (inter particular porosity 
and cohesive index) of Furosemide by addition of the MCC 
and cross carmellose sodium that they shows the 
compressibility parameters (Ie & Icd) near to the acceptable 
mean values 4.914 and 4.97 respectively and banana 
powder shows 5.29 which was largest mean value in all 
among and improve the compressibility of Furosemide. 
Cohesive index for the stability of drug and by addition of 
this above excipients stability of drug also improved. The 
flow property (angle of repose & flow property) was 
improved by addition of MCC and banana powder. LOD of all 
parameter were good enough, and it measured the amount 
of water and volatile matter present in the sample when the 
sample was dried under specific temperature condition. 
High hygroscopicity is undesirable for many reasons that 
include handling problem, storage conditions, physical 
stability and chemical stability problem. By addition of 
excipients having mean value above the acceptable limit 
were fulfil the requirement of the API and increases the 
compressibility and flow rate of Furosemide. Index value by 
SeDeM required amount of excipient was calculated and 
shown in Table 4. 
Table 4: Index Value 
Parameter IPP IP IGC 
Furosemide 5.21 0.42 4.96 
Mannitol 5.66 0.66 5.39 
MCC 5.57 0.5 5.3 
Aspartame 5.23 0.5 4.98 
CCS 5.57 0.5 5.3 
Magnesium Stearate 5.65 0.58 5.38 
Natural Polymer 5.79 0.75 5.51 
 
Formulations and development of Furosemide oral 
disintegrating tablets 
Two different Furosemide containing ODT formulations 
were developed by using cross carmellose sodium and 
banana powder as a super disintegrants. All six formulation 
blend was further processed through SeDeM parameters in 
order to finalized optimized formulation, values reported in 
Table 5. 
 
 
Table 5: Radius parameters, mean incidence and parametric index for blend 
Formulation F1 F2 F3 F4 F5 F6 
Radius values 
Da 5 5 4.8 5 5 4.55 
Dc 5.6 6.3 5.9 6.7 6.3 6.25 
Ie 1.7 3.3 3.3 4.2 3.3 5 
Ic 8 6 6.2 5 6 4.55 
Icd 6 7.7 7 6 6.6 5.55 
IH 6.3 5.8 5.9 5.6 5.8 5.42 
(a) 6.1 5.2 5.7 3.5 4.3 4.84 
t''n 4.5 3.5 2.5 5.5 4 3 
LOD 5.9 6.5 4.8 4.2 3.7 6.67 
% H 9.9 10 10 10 10 9.95 
% Pf 9.6 9.7 9.6 9.6 9.8 9.82 
(IQ) 2.6 3 1.3 1 1.1 1.49 
Incidence Factor 
Dimension 5.3 5.6 5.3 5.8 5.6 5.4 
Compressibility 5.2 5.7 5.5 5.1 5.3 5.03 
Flowability/ Powder flow 5.6 4.9 4.7 4.8 4.7 4.42 
Lubricity/ Stability 7.9 8.2 7.4 7.1 6.9 8.31 
Lubricity/ Dosage 6.1 6.3 5.4 5.3 5.4 5.65 
Index 
IPP 5.9 6 5.6 5.5 5.5 5.59 
IP 0.8 0.8 0.6 0.7 0.6 0.66 
IGC 5.7 5.7 5.3 5.3 5.2 5.32 
 
The blend of excipients and drug was nearer to the 
acceptable range and dimension, compressibility lubricity, 
stability and compressible because it shows all values are 
above the acceptable limit 5. From the results, formulation 
F4 containing natural super disintegrants was reliable in all 
parameters among natural formulations (F4, F5, and F6) 
which show IGC, IP and IPP were 5.24, 0.66 and 5.509 
respectively. Formulation F3 containing synthetic super 
disintegrants was good for the compression by its IGC, IP 
and IPP value were 5.30, 0.58 and 5.57 among all batches 
(figure 3). All 12 parameters of the SeDeM were obtained 
within limit and showed good flow property required for 
direct compression method. 
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Figure 3: SeDeM diagram of furosemide ODT 
Post formulation evaluation 
The post compression parameter was performed and results were tabulated in Table 6.  
Table 6: Evaluation of Post-compression parameters 
Parameter F1 F2 F3 F4 F5 F6 
Thickness 4.4±0.12 4.5±0.14 4.3±0.07 4.5±0.04 4.5±0.13 4.4±0.10 
Friability (%) 0.94±0.06 0.83±0.04 0.86±0.08 0.88±0.07 0.97±0.06 0.92±0.03 
Hardness kg/cm2) 2.3±0.08 2.4±0.15 2.5±0.18 2.4±0.16 2.5±0.19 2.3±0.09 
Diameter (mm) 8 8 8 8 8 8 
weight variation 199.5±0.70 200.5±0.70 201±1.41 200.5±0.70 201±0.1 200±1.41 
Drug content uniformity 100.8±0.18 95.16±0.24 96.65±0.64 100.5±0.09 98.61±0.12 96.89±0.21 
Disintegration time (sec) 143±2.82 157.5±2.12 173.5±0.7 16±1.41 34±2.82 129.5±2.12 
wetting time (sec) 100±1.41 53±2.82 14±2.82 10±2.82 20±2.82 41±2.82 
Water absorption ratio (%) 56.40±1.9 35.85±4.7 64.40±3.9 117.59±4.2 118.25±2.4 43.70±3.3 
All values are expressed as mean± standard deviation 
 
The thickness of tablets was found to be 4.3±0.07 to 4.5±0.14 
mm while hardness results were in the range of 2.3±0.08 to 
2.4±0.16 kg/cm². The drug content for all formulation was 
found to be in the range of 96.89±0.21-100.5±0.09% which 
was within the acceptable limits. All the formulations 
disintegrated within 173.5±0.70 second. Formulations with 
Banana powder as superdisintegrant showed faster 
disintegration than Ac-di-sol formulations. Tablets obtained 
were of uniform weight with acceptable variation as per IP 
specifications i.e. below 7.5%. From the result, formulation 
F4 shows 10±2.82 second, 117.59±4.22 and 16±1.41second 
respectively for wetting time (less), water absorption 
capacity (high), and disintegration time (less) having all this 
values in acceptable range while F1 shows very poor wetting 
time 100±1.41 sec, water absorption ratio 56.40±1.90 % and 
disintegration time 143±2.82 second (Table 6). In-vitro drug 
release studies were performed and shown in figure 4. The 
formulations which contain banana powder (F4) as super 
disintegrating agent has shown 99.41% of drug release, 
formulations with Ac-di-sol (F3) as super disintegrating 
agent has shown 91.5% of drug release at the end of 10 min. 
Banana powder due to its water absorption ratio 
(117.59±4.22%) created enough hydrodynamic pressure for 
quick and complete disintegration of the tablet. 
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Figure 4: In-vitro release profile of formulation F1-F6 
 
From the results, formulation F3 and F4 showed the good 
effect on fast disintegration and dissolution time period 
(91.5% and 99.41 % within 10 respectively). Stability 
studies for the optimised formulation F4 were carried out by 
storing the selected formulation at 40°C±2°C/75%±5% RH 
for three months tabulated in Table 7. For every one month 
interval the tablets were analyzed for the colour, friability, 
hardness and in-vitro drug release. There was no 
significance change in all the parameters. The F1 
(dissimilarity value) and F2 (similarity value) for drug 
release profile at 30±20C and 65±5% RH were 3.07 and 
72.02 respectively while for drug release at 40±20C and 
75±5%RH were 2.51 and 78.51 respectively which indicated 
that the formulation was stable after 90 days and complies 
for stability test.  
 
Time  
(days) 
Condition Drug Content 
Hardness 
(kg/cm2) 
In-vitro dissolution 
after 10 min 
At 0 stage -- 99.5±0.09 2.46±0.05 99.58 
after 30  
30±20C & 65±5% RH 99.33±0.045 2.43±0.11 97.95 
40±20C & 75±5% RH 99.78±0.09 2.4±0.09 97.56 
after 90  
30±20C & 65±5% RH 98.29±0.64 2.3±0.05 98.68 
40±20C & 75±5%RH 98.14±0.62 2.3±0.09 98.52 
  
 
CONCLUSION 
SeDeM system gives accurate prediction of material of poor 
flow and reduces the number of batches and cost. SeDeM 
design system is helpful for formulation and development of 
Furosemide oral disintegrating tablets and formulation F4 
containing natural polymer (Banana powder) are suitable 
and reliable super disintegrants  in order to improve 
disintegration/dissolution of the drug in oral cavity as 
compared to synthetic polymer (Cross carmellose cellulose) 
for formulation of oral disintegrating tablets by direct 
compression method.  
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